期刊文献+

药物治疗的风险及其处理 被引量:2

The Risks of Drug Therapy and It's Managements
下载PDF
导出
摘要 造成药物治疗风险的因素包括药物因素、病情因素、患者因素、用药因素及管理因素等。通过对药物进行严格监管,对医药从业人员加强培训和教育,对民众开展科普教学和用药指导,可以降低药物治疗的风险。风险事件主要表现为用药差错、药物不良反应或药物治疗无效。在药物治疗中,首先必须时刻警惕和及时发现风险;其次需要全面评估风险,还要对疾病风险和药物治疗风险进行比较。应尽可能避免药物治疗的风险,对于必须承受的风险,需采取相应措施,减少风险事件发生的概率和严重程度。如果存在较大风险,务必同时设计处理风险事件的预案,并与患者及其家属保持良好的交流和沟通。 The risks for treatment related to drugs including the characters of drugs ,illness and patients ,as well as the drugs itself and management of drugs .Some measures could reduce the risks of drug therapy ,such as developing new safe and effective drugs ,training and educating medical workers ,promoting popular science education and drug guidance to people .The manifestations of risk events of drug therapy primarily showed in medication errors ,adverse drug reaction , and poor effects of drug therapy .Factors which could induce or prompt the risk events are known as risk promoting factors .In drug therapy ,we must be on guardant and discover the risks in time .As soon as discovering risk of drug , thorough assessment the risks should be completed ,as well as comparing the risks of disease with that of drug therapy . We should do our best to avoid the risks ,or reduce the possibility and degree of the risk events if necessary .
出处 《医学与哲学(B)》 2014年第4期1-3,29,共4页 Medicine & Philosophy(B)
关键词 药物治疗 风险因素 风险事件 drug therapy risk factors risk events
  • 相关文献

参考文献9

二级参考文献105

  • 1曹荣桂.以医院管理年为契机 提高医院服务水平[J].中国医院,2005,9(7):1-5. 被引量:49
  • 2温伟,纪立伟,张新超.胺碘酮静脉滴注致急性肝损害15例临床分析[J].药物不良反应杂志,2006,8(2):105-109. 被引量:38
  • 3Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502. 被引量:1
  • 4Kim KA,Park PW,Hong SJ,et al.The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel:a possible mechanism for clopidogrel resistance.Clin Pharmacol Ther,2008,84:236-242. 被引量:1
  • 5Simon T,Verstuyft C,Mary-Krause M,et al.Genetic determinants of response to clopidogrel and cardiovascular events.N Engl J Med,2009,360:363-375. 被引量:1
  • 6Bhatt DL,Scheiman J,Abraham NS,et al.ACCF/ACG/ AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.Circulation,2008,118:1894-1909. 被引量:1
  • 7Ho PM,Maddox TM,Wang L,et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.JAMA,2009,301:937-944. 被引量:1
  • 8Aubert RE,Epstein RS,Teagarden JR,et al.Proton pump inhibitors effect on clopidogrel effectiveness:The Clopidogrel Medco Outcomes Study.Circulation,2008,118:S815 (AB3998). 被引量:1
  • 9Pezalla E,Day D,Pulliadath I,et al.Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors.J Am Coll Cardiol,2008,52,1038-1039. 被引量:1
  • 10Gilard M,Arnaud B,Cornily JC,et al.Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin;the randomized,double-blind OCLA(Omeprazole Clopidogrel Aspirin) study.J Am Coll Cardiol,2008,51:256-260. 被引量:1

共引文献61

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部